Ads
related to: multiple myeloma- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Contact a Representative
For Questions and Information
About This Treatment
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Primary and Subgroup Data
Search results
Report shows disparities in cancer outcomes based on race, location, sexuality
United Press International via Yahoo News· 7 days agoRace, location and sexuality all play a role in cancer disparities across the United States,...
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
BioPharma Dive via Yahoo Finance· 6 days agoThe deal is part of a plan by J&J to build a portfolio of “differentiated” bispecific antibodies, an...
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 days agoNew drug Carvykti, a BCMA CAR-T therapy approved in 2022 for relapsed or refractory multiple myeloma...
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
InvestorPlace· 2 days agoAmid the rise of the digital innovation space, investors may want to consider biotech stocks to buy....
Dodgers milestones: 5 players reflect on 10 years of big-league service
New York Times· 5 days agoAfter a breezy, if unspectacular win over the Minnesota Twins last month, the Los Angeles Dodgers...
Purses' auction to support cancer patients, caregivers
WISH-TV Indianapolis· 6 days agoA group is using purses and philanthropy together for a good cause. Purses with Purpose aims to...
Donna Lynne Harman Garrett
WDTV· 1 day agoDonna Lynne Harman Garrett
Novel Heart Device Lead Sails Through Performance Hurdles
MedPage Today· 4 days agoA novel small-diameter lead wire had a high level of success for delivery of implantable...
Cool Teachers: Mrs. Jodi Caruso and Mrs. Suzi Cunningham
WCBD-TV Charleston· 7 days agoWe just celebrated Mother’s Day, and a mother-daughter teaching duo at St. Andrew’s School of Math...
Research explains new method to engineer immune cells that could treat multiple cancer patients
Medical Xpress· 5 days agoTo tackle these limitations, UCLA researchers have developed a new, clinically guided method to engineer more powerful immune cells called invariant natural killer T cells, or iNKT cells, that ...